(VIANEWS) – YARA INTERNATIONAL (YAR.OL), UCB (UCB.BR), DOCK.PETR.AMBES AM (DPAM.PA) are the highest payout ratio stocks on this list.
We have gathered information concerning stocks with the highest payout ratio as yet. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. YARA INTERNATIONAL (YAR.OL)
226.21% Payout Ratio
Yara International ASA provides crop nutrition and industrial solutions in Norway, European Union, Europe, Africa, Asia, North and Latin America, Australia, and New Zealand. The company offers ammonium- and urea-based fertilizers; compound fertilizers that contain plant nutrients, such as nitrogen, phosphorus, and potassium; coatings; biostimulants; organic-based fertilizers; green fertilizers are nitrate-based mineral fertilizers, as well as foliar and fertigation solutions; and nitrate, calcium nitrate, micronutrient, and fertigation fertilizers. It also offers digital solutions, such as variable rate application solutions; N-Sensor, a tractor-mounted hardware; N-Tester, a hand held nitrogen measurement tool; and Atfarm, a digital toolbox for farmer. The company sells its products under YaraBela, YaraMila, YaraLiva, YaraVita, YaraRega, YaraTera, YaraSuna, and YaraVera and brands. Yara International ASA was founded in 1905 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, YARA INTERNATIONAL has a trailing twelve months EPS of kr23.63.
PE Ratio
YARA INTERNATIONAL has a trailing twelve months price to earnings ratio of 14.28. Meaning, the purchaser of the share is investing kr14.28 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.68%.
Volume
Today’s last reported volume for YARA INTERNATIONAL is 180599 which is 63.32% below its average volume of 492470.
More news about YARA INTERNATIONAL.
2. UCB (UCB.BR)
78.24% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €1.7.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 48.73. Meaning, the purchaser of the share is investing €48.73 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.7%.
Yearly Top and Bottom Value
UCB’s stock is valued at €82.84 at 11:10 EST, below its 52-week high of €88.80 and way higher than its 52-week low of €65.40.
More news about UCB.
3. DOCK.PETR.AMBES AM (DPAM.PA)
76.86% Payout Ratio
Les Docks des Pétroles d'Ambès -SA engages in the storage and shipping of petroleum products in France. It stores and distributes species, diesel, and combustibles, as well as bio, jet, technical, and marine fuel products. The company was founded in 1930 and is based in Carbon-Blanc, France.
Earnings Per Share
As for profitability, DOCK.PETR.AMBES AM has a trailing twelve months EPS of €49.43.
PE Ratio
DOCK.PETR.AMBES AM has a trailing twelve months price to earnings ratio of 9.59. Meaning, the purchaser of the share is investing €9.59 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.86%.
Volume
Today’s last reported volume for DOCK.PETR.AMBES AM is 40 which is 344.44% above its average volume of 9.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 17.96M for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 21, 2023, the estimated forward annual dividend rate is 38 and the estimated forward annual dividend yield is 8.41%.
Moving Average
DOCK.PETR.AMBES AM’s worth is above its 50-day moving average of €470.12 and below its 200-day moving average of €479.39.
More news about DOCK.PETR.AMBES AM.
4. CAPGEMINI (CAP.PA)
34.03% Payout Ratio
Capgemini SE provides consulting, digital transformation, technology, and engineering services primarily in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company offers strategy and transformation services, including strategy, technology, data science, and creative design to support various clients within the digital economy. It also provides applications and technology services that helps the clients to develop, modernize, extend, and secure their IT and digital environment using the latest technologies, as well as offers local technology services in cloud, cybersecurity, quality assurance, testing, and new technology fields. In addition, the company offers business process outsourcing and transactional services, as well as installation and maintenance services for its clients' IT infrastructures in data centers or in the cloud. It serves various industries, including consumer goods and retail; energy and utilities; banking, capital markets, and insurance; manufacturing and life sciences; public sector; telecommunications, media, and technology; and services. Capgemini SE has strategic partnerships with CONA Services LLC to develop digital solutions for the consumer products industry and retail customers; and Innoveo Inc. to deliver digital transformation solutions to insurance clients across various lines of business. The company was founded in 1967 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, CAPGEMINI has a trailing twelve months EPS of €9.56.
PE Ratio
CAPGEMINI has a trailing twelve months price to earnings ratio of 21.24. Meaning, the purchaser of the share is investing €21.24 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.8%.
Moving Average
CAPGEMINI’s worth is above its 50-day moving average of €186.94 and way above its 200-day moving average of €172.10.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 30, 2023, the estimated forward annual dividend rate is 3.25 and the estimated forward annual dividend yield is 1.65%.
Volume
Today’s last reported volume for CAPGEMINI is 212900 which is 35.83% below its average volume of 331790.
Yearly Top and Bottom Value
CAPGEMINI’s stock is valued at €203.10 at 11:10 EST, higher than its 52-week high of €199.05.
More news about CAPGEMINI.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 1% and 1%, respectively.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).
More news about 1.
